Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
17.89
-0.19 (-1.05%)
At close: Jun 11, 2025, 4:00 PM
18.05
+0.16 (0.89%)
Pre-market: Jun 12, 2025, 8:04 AM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $1.74 billion as of June 12, 2025. Its market cap has decreased by -7.95% in one year.
Market Cap
1.74B
Enterprise Value
682.21M
1-Year Change
-7.95%
Ranking
Category
Stock Price
$17.89
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $1.74B, an increase of 431.76%. That is a compound annual growth rate of 36.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2025 | 1.76B | -10.71% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.89B |
| Johnson & Johnson | 376.38B |
| Novo Nordisk | 353.20B |
| AbbVie | 334.65B |
| UnitedHealth Group | 275.67B |
| Abbott Laboratories | 233.19B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |